Bath & Body Works, Inc. $BBWI Shares Purchased by Frazier Financial Advisors LLC

Frazier Financial Advisors LLC increased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 10.4% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 48,876 shares of the company’s stock after acquiring an additional 4,594 shares during the period. Bath & Body Works makes up about 1.0% of Frazier Financial Advisors LLC’s portfolio, making the stock its 18th largest holding. Frazier Financial Advisors LLC’s holdings in Bath & Body Works were worth $1,464,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in Bath & Body Works in the 2nd quarter valued at about $33,000. SVB Wealth LLC purchased a new position in Bath & Body Works in the 1st quarter worth approximately $35,000. Geneos Wealth Management Inc. lifted its stake in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC lifted its stake in Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares in the last quarter. Finally, Golden State Wealth Management LLC lifted its stake in Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after purchasing an additional 642 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Stock Up 3.5%

NYSE:BBWI opened at $25.89 on Tuesday. The company has a fifty day simple moving average of $27.96 and a two-hundred day simple moving average of $29.22. The company has a market cap of $5.34 billion, a price-to-earnings ratio of 7.68, a price-to-earnings-growth ratio of 0.86 and a beta of 1.52. Bath & Body Works, Inc. has a 52 week low of $24.85 and a 52 week high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting the consensus estimate of $0.37. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company’s quarterly revenue was down .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.1%. Bath & Body Works’s payout ratio is presently 23.74%.

Analyst Upgrades and Downgrades

BBWI has been the topic of several analyst reports. Wall Street Zen lowered shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. UBS Group reduced their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research report on Friday, August 29th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. Jefferies Financial Group set a $28.50 price target on shares of Bath & Body Works in a research report on Monday. Finally, Barclays lifted their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an “equal weight” rating in a report on Friday, August 29th. Eleven research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Bath & Body Works currently has a consensus rating of “Moderate Buy” and an average target price of $37.46.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.